BlackRock’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.55M | Sell |
445,382
-718,119
| -62% | -$4.13M | ﹤0.01% | 4098 |
|
|
2026
Q1 | $7.31M | Sell |
1,163,501
-31,210
| -3% | -$290K | ﹤0.01% | 3676 |
|
|
2025
Q4 | $14.6M | Buy |
1,194,711
+6,870
| +0.6% | +$112K | ﹤0.01% | 3262 |
|
|
2025
Q3 | $24.4M | Sell |
1,187,841
-33,992
| -3% | -$539K | ﹤0.01% | 2969 |
|
|
2025
Q2 | $16.5M | Sell |
1,221,833
-99,305
| -8% | -$1.09M | ﹤0.01% | 3145 |
|
|
2025
Q1 | $11.4M | Sell |
1,321,138
-14,360
| -1% | -$87.8K | ﹤0.01% | 3249 |
|
|
2024
Q4 | $6.49M | Buy |
1,335,498
+60,737
| +5% | +$339K | ﹤0.01% | 3620 |
|
|
2024
Q3 | $9.84M | Buy |
1,274,761
+99,358
| +8% | +$883K | ﹤0.01% | 3417 |
|
|
2024
Q2 | $11.8M | Buy |
1,175,403
+90,127
| +8% | +$990K | ﹤0.01% | 3289 |
|
|
2024
Q1 | $13.2M | Sell |
1,085,276
-49,678
| -4% | -$720K | ﹤0.01% | 3204 |
|
|
2023
Q4 | $16.2M | Buy |
1,134,954
+33,804
| +3% | +$324K | ﹤0.01% | 3121 |
|
|
2023
Q3 | $8.57M | Sell |
1,101,150
-9,207
| -0.8% | -$100K | ﹤0.01% | 3426 |
|
|
2023
Q2 | $15.9M | Buy |
1,110,357
+68,619
| +7% | +$977K | ﹤0.01% | 3176 |
|
|
2023
Q1 | $15.2M | Sell |
1,041,738
-1,672,452
| -62% | -$28M | ﹤0.01% | 3100 |
|
|
2022
Q4 | $45.6M | Sell |
2,714,190
-59,312
| -2% | -$1.03M | ﹤0.01% | 2535 |
|
|
2022
Q3 | $41.1M | Buy |
2,773,502
+70,139
| +3% | +$1.39M | ﹤0.01% | 2594 |
|
|
2022
Q2 | $74M | Buy |
2,703,363
+19,489
| +0.7% | +$578K | ﹤0.01% | 2222 |
|
|
2022
Q1 | $101M | Buy |
2,683,874
+15,786
| +0.6% | +$699K | ﹤0.01% | 2131 |
|
|
2021
Q4 | $166M | Buy |
2,668,088
+1,559,669
| +141% | +$118M | ﹤0.01% | 1881 |
|
|
2021
Q3 | $94.8M | Buy |
1,108,419
+4,262
| +0.4% | +$267K | ﹤0.01% | 2253 |
|
|
2021
Q2 | $68.3M | Buy |
1,104,157
+25,268
| +2% | +$1.29M | ﹤0.01% | 2486 |
|
|
2021
Q1 | $52.6M | Buy |
1,078,889
+93,779
| +10% | +$4.52M | ﹤0.01% | 2579 |
|
|
2020
Q4 | $30.7M | Buy |
985,110
+48,014
| +5% | +$1.18M | ﹤0.01% | 2778 |
|
|
2020
Q3 | $19.5M | Sell |
937,096
-27,133
| -3% | -$466K | ﹤0.01% | 2867 |
|
|
2020
Q2 | $12.6M | Buy |
964,229
+28,378
| +3% | +$308K | ﹤0.01% | 3052 |
|
|
2020
Q1 | $8.48M | Sell |
935,851
-2,585
| -0.3% | -$24.5K | ﹤0.01% | 3085 |
|
|
2019
Q4 | $9.64M | Buy |
938,436
+162,921
| +21% | +$1.85M | ﹤0.01% | 3263 |
|
|
2019
Q3 | $11.2M | Buy |
775,515
+168,223
| +28% | +$2.6M | ﹤0.01% | 3153 |
|
|
2019
Q2 | $9.84M | Buy |
607,292
+579,833
| +2,112% | +$7.83M | ﹤0.01% | 3263 |
|
|
2019
Q1 | $350K | Buy |
27,459
+22,462
| +450% | +$292K | ﹤0.01% | 4153 |
|
|
2018
Q4 | $55K | Buy |
+4,997
| New | +$73.9K | ﹤0.01% | 4462 |
|
Other funds holding OPRX
WCA
RA
KCM
RHJA
PHP
BAM
BlackRock's OPRX Position: Q2 2026 in Review
BlackRock reduced its OptimizeRx (OPRX) stake by 62% in Q2 2026, selling an estimated $4.13M and leaving 445,382 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #4098.
BlackRock first reported a position in OPRX in Q4 2018 and has held it in 31 quarters since. The position peaked at $166M in Q4 2021. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.
- BlackRock held 445,382 shares of OptimizeRx worth $2.55M as of Q2 2026.
- BlackRock sold 718,119 OptimizeRx shares in Q2 2026, an estimated $4.13M.
- OptimizeRx made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4098 holding.
- BlackRock first reported a position in OptimizeRx in Q4 2018 and has held it in 31 quarters since.
- BlackRock's OptimizeRx position peaked at $166M in Q4 2021.
- 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.